Bentsur Ron

Nuvectis Pharma, Inc. · Chairman & CEO

Bentsur Ron is listed in public filings as director, 10 percent owner, officer: Chairman & CEO. This Bentsur Ron insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Nuvectis Pharma, Inc. (NVCT). Investors use Bentsur Ron's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Nuvectis Pharma, Inc.NVCT$29k5k sharesBuyNov 5, 2025$5.72--